From Investing.com: 2024-05-09 12:29:14

National Vision Holdings, Inc. (EYE) reported a 4.2% increase in net revenues for Q1 2024 and a 0.4% rise in adjusted comparable store sales. The company is expanding remote exam technology to over 550 locations, aiming for 700 by year-end. National Vision received its second FDA breakthrough designation for an AI-based chronic kidney disease assessment tool.

Despite challenges like a slower category growth and a lackluster tax return season, National Vision remains positive and focused on growth and expense management. The company’s remote exam technology and AI integration set it apart in the optical retail industry. National Vision’s strong foundation and strategic initiatives position it for potential growth and success.



Read more at Investing.com: National Vision sees growth with remote exams and AI focus By Investing.com